|
|
About BLUE HIGHWAY
Any sufficiently advanced technology is indistinguishable from magic.
—Arthur C. Clarke BLUE HIGHWAY is a wholly owned subsidiary of Welch Allyn, a privately held leader in front-line diagnostic healthcare. Officially, BLUE HIGHWAY was formed to “create economic value through new customer insight, products or services, policy and regulatory insight, or business models."
In plain language, BLUE HIGHWAY exists to innovate. And innovation is really about capitalizing on invention. The way we see it, there are three kinds of innovation:
Incremental innovation – The evolutionary improvement of the technology for an existing practice (e.g., a device to measure blood pressure on the “inflate” instead of the “deflate”). It is based on known needs of customers and sustains or increases market share.
Radical innovation – Developing completely new technology for an existing practice (e.g., a device to measure blood pressure without a cuff). It is based on predicted needs of customers and explodes a market.
Breakthrough innovation – Inventing revolutionary new technology for new clinical practice (e.g., a device to measure a new vital sign that will replace/displace blood pressure measuring completely) that has the potential to spawn entirely new markets.
At BLUE HIGHWAY, our primary focus is on disruptive and breakthrough innovations in our core technical areas.
|